Lantern Pharma Inc (LTRN)
6.23
-0.23
(-3.56%)
USD |
NASDAQ |
May 23, 16:00
6.10
-0.13
(-2.09%)
After-Hours: 20:00
Lantern Pharma Cash and Short Term Investments (Quarterly): 38.36M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 38.36M |
| December 31, 2023 | 41.30M |
| September 30, 2023 | 44.93M |
| June 30, 2023 | 47.95M |
| March 31, 2023 | 51.54M |
| December 31, 2022 | 55.20M |
| September 30, 2022 | 57.83M |
| June 30, 2022 | 62.15M |
| March 31, 2022 | 65.22M |
| Date | Value |
|---|---|
| December 31, 2021 | 70.73M |
| September 30, 2021 | 73.83M |
| June 30, 2021 | 79.59M |
| March 31, 2021 | 81.37M |
| December 31, 2020 | 19.23M |
| September 30, 2020 | 20.80M |
| June 30, 2020 | 23.80M |
| March 31, 2020 | 0.6342M |
| December 31, 2019 | 1.232M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.6342M
Minimum
Mar 2020
81.37M
Maximum
Mar 2021
46.43M
Average
49.74M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eyenovia Inc | 7.976M |
| Cassava Sciences Inc | 124.17M |
| Alpine Immune Sciences Inc | 305.66M |
| Clearside Biomedical Inc | 35.36M |
| Poseida Therapeutics Inc | 198.65M |